Clinical trials
Phase 2 Presbyopia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allergan | 4 |
| LENZ Therapeutics, Inc | 4 |
| Novartis Pharmaceuticals | 2 |
| Glaukos Corporation | 1 |
| Ocuphire Pharma, Inc. | 1 |
| Orasis Pharmaceuticals Ltd. | 1 |
| Santen Inc. | 1 |
| Visus Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Presbyopia | 15 |
| Refractive Errors | 3 |
| Eye Diseases | 2 |
| Myopia | 2 |
| Hyperopia | 1 |
| Lens Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.